Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6547)
All Articles published online
|
Publishing Process of This Article
|
Sep 8, 2015 (publication date) through May 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ampuero J, Romero-Gómez M. Assessing cardiovascular risk in hepatitis C: An unmet need. World J Hepatol 2015; 7(19): 2214-2219 [PMID: 26380047 DOI: 10.4254/wjh.v7.i19.2214] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i19/2214.htm |
| Number | Citing Articles |
| 1 |
M.F. Bassendine, S.U. Nielsen, S.H. Bridge, D.J. Felmlee, D.A. Sheridan, C.J. Packard, R.D. Neely. Hepatitis C virus and atherosclerosis: A legacy after virologic cure?. Clinics and Research in Hepatology and Gastroenterology 2017; 41(1): 25 doi: 10.1016/j.clinre.2016.09.008
|
| 2 |
Kamolyut Lapumnuaypol, David Pisarcik, Prapaipan Putthapiban, Weera Sukhumthammarat, Karn Wijarnpreecha, Charat Thongprayoon, Patompong Ungprasert. Direct-acting antiviral agents decrease haemoglobin A1c level in patients with diabetes infected with hepatitis C virus: A systematic review & meta-analysis. Indian Journal of Medical Research 2020; 152(6): 562 doi: 10.4103/ijmr.IJMR_1088_18
|
| 3 |
Michael Broker, Shalom Z. Frager, Nayan S. Patel, Edward Lebovics, William H. Frishman. The Inflammatory Relationship Between Hepatitis C Virus With Coronary and Carotid Atherosclerosis. Cardiology in Review 2021; 29(4): 178 doi: 10.1097/CRD.0000000000000314
|
| 4 |
Isabel Conde, Carmen Vinaixa, Marina Berenguer. Cirrosis por hepatitis C. Estado actual. Medicina Clínica 2017; 148(2): 78 doi: 10.1016/j.medcli.2016.09.019
|
| 5 |
Stefano GITTO, Carmela CURSARO, Alessandra BARTOLI, Marzia MARGOTTI, Pietro ANDREONE. Hepatitis C: clinical management and debated issues. Minerva Medica 2021; 112(2) doi: 10.23736/S0026-4806.20.07208-0
|
| 6 |
Dalia A Freekh, Maged W Helmy, Mohamed Said, Noha M El-khodary. The effect of direct acting antiviral agents on vascular endothelial function in Egyptian patients with chronic hepatitis C virus infection. Saudi Pharmaceutical Journal 2021; 29(10): 1120 doi: 10.1016/j.jsps.2021.08.006
|
| 7 |
Nicolas Musigk, Phillip Suwalski, Ainoosh Golpour, DeLisa Fairweather, Karin Klingel, Pilar Martin, Andrea Frustaci, Leslie T. Cooper, Thomas F. Lüscher, Ulf Landmesser, Bettina Heidecker. The inflammatory spectrum of cardiomyopathies. Frontiers in Cardiovascular Medicine 2024; 11 doi: 10.3389/fcvm.2024.1251780
|
| 8 |
Simon H. Bridge, Sabrina Pagano, Meleri Jones, Graham R. Foster, Dermot Neely, Nicolas Vuilleumier, Margaret F. Bassendine. Autoantibody to apolipoprotein A-1 in hepatitis C virus infection: a role in atherosclerosis?. Hepatology International 2018; 12(1): 17 doi: 10.1007/s12072-018-9842-5
|
| 9 |
Isabel Conde, Carmen Vinaixa, Marina Berenguer. Hepatitis C-related cirrhosis. Current status. Medicina Clínica (English Edition) 2017; 148(2): 78 doi: 10.1016/j.medcle.2016.09.035
|
| 10 |
Amilcar L Morales, Zachary Junga, Manish B Singla, Maria Sjogren, Dawn Torres. Hepatitis C eradication with sofosbuvir leads to significant metabolic changes. World Journal of Hepatology 2016; 8(35): 1557-1563 doi: 10.4254/wjh.v8.i35.1557
|
| 11 |
Victoria Aguilera, Tommaso Di Maira, Isabel Conde, Victoria Fornés-Ferrer, Carmen Vinaixa, Carmen Pallarés, Angela Carvalho-Gomes, Almudena Cubells, María García, Ángel Rubín, Salvador Benlloch, Luisa Gonzalez-Dieguez, Jose Miguel Molina, Lorena Puchades, F. Xavier López-Labrador, Martin Prieto, Marina Berenguer. Cytomegalovirus reactivation in liver transplant recipients due to hepatitis C cirrhosis is associated with higher cardiovascular risk - an observational, retrospective study. Transplant International 2018; 31(6): 649 doi: 10.1111/tri.13145
|
| 12 |
Rocío Muñoz-Hernández, Javier Ampuero, Raquel Millán, Antonio Gil-Gómez, Ángela Rojas, Hada C. Macher, Rocío Gallego-Durán, Sheila Gato, Rocío Montero-Vallejo, María C. Rico, Douglas Maya-Miles, Yolanda Sánchez-Torrijos, Isabel Carmona Soria, Pablo Stiefel, Manuel Romero-Gómez. Hepatitis C Virus Clearance by Direct-Acting Antivirals Agents Improves Endothelial Dysfunction and Subclinical Atherosclerosis: HEPCAR Study. Clinical and Translational Gastroenterology 2020; 11(8): e00203 doi: 10.14309/ctg.0000000000000203
|
| 13 |
Ryo Fukuda, Yasuteru Kondo. Hepatitis C virus infection could affect the pathogenesis of ischemic heart diseases in northern Japan. Hepatology Research 2019; 49(3): 355 doi: 10.1111/hepr.13283
|
| 14 |
Adauto CASTELO, Carlos Eduardo BRANDÃO MELLO, Rosangela TEIXEIRA, Jose Valdez Ramalho MADRUGA, Tania REUTER, Leila Maria Moreira Beltrão PEREIRA, Giovanni Faria SILVA, Mario Reis ÁLVARES-DA-SILVA, Heverton ZAMBRINI, Paulo Roberto Abrão FERREIRA. HEPATITIS C IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM: BURDEN OF DISEASE. Arquivos de Gastroenterologia 2018; 55(4): 329 doi: 10.1590/s0004-2803.201800000-74
|
| 15 |
Frank P. Schmidt, Tim Zimmermann, Till Wenz, Boris Schnorbus, Mir Abolfazl Ostad, Christina Feist, Annette Grambihler, Jörn M. Schattenberg, Martin F. Sprinzl, Thomas Münzel, Peter R. Galle. Interferon- and ribavirin-free therapy with new direct acting antivirals (DAA) for chronic hepatitis C improves vascular endothelial function. International Journal of Cardiology 2018; 271: 296 doi: 10.1016/j.ijcard.2018.04.058
|
| 16 |
Ashraf Abd El-Khalik Barakat, Fatma Mohammad Nasr, Amna Ahmed Metwaly, Sherif Morsy, Mervat Eldamarawy. Atherosclerosis in chronic hepatitis C virus patients with and without liver cirrhosis. The Egyptian Heart Journal 2017; 69(2): 139 doi: 10.1016/j.ehj.2016.10.004
|
| 17 |
Mohsen Gadallah, Sahar Kandil, Amira Mohsen. Association between hepatitis C infection and cerebro‐cardiovascular disease: analysis of a national population‐based survey in Egypt. Tropical Medicine & International Health 2018; 23(7): 738 doi: 10.1111/tmi.13068
|
| 18 |
Nick Nielsen, Sofie Jespersen, Julie Gaardbo, Caroline Arnbjerg, Mette Clausen, Mette Kjær, Jan Gerstoft, Vibe Ballegaard, Sisse Ostrowski, Susanne Nielsen. Impaired Platelet Aggregation and Rebalanced Hemostasis in Patients with Chronic Hepatitis C Virus Infection. International Journal of Molecular Sciences 2017; 18(5): 1016 doi: 10.3390/ijms18051016
|
| 19 |
Fabrizio Fabrizi, Francesca M. Donato, Piergiorgio Messa. Hepatitis C and Its Metabolic Complications in Kidney Disease. Annals of Hepatology 2017; 16(6): 851 doi: 10.5604/01.3001.0010.5275
|